Satori Capital is a Dallas-based private equity firm specializing in management buy-outs, acquisitions, mergers, recapitalizations, and corporate restructuring. The firm primarily invests in Series A and B rounds, with a focus on creating long-term value for all stakeholders. Satori's investment approach encompasses more than just capital, offering experience, relationships, and guidance to portfolio companies.
Led by principals with experience in building successful companies and managing multi-billion-dollar investment firms, Satori provides valuable operational expertise to its portfolio companies. Notable investments include Bond Pet Foods, Gilgamesh Pharmaceuticals, and Lykos Therapeutics. The firm's philosophy emphasizes enduring value creation and leverages its team's extensive experience to steer leadership teams toward sustainable growth.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.